Percutaneous mitral annuloplasty. Francesco Maisano MD, FESC San Raffaele Hospital Milano, Italy

Similar documents
Percutaneous mitral valve repair/replacement. Jan Van der Heyden MD, PhD St.Antonius Hospital Nieuwegein

Mitral regurgitation (MR) is the second most

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France

Percutaneous Therapy for Mitral Regurgitation: Current and Future Options: Could we do better today?

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines

Current status: Percutaneous mitral valve therapy

Percutaneous mitral valve repair: current techniques and results

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Emerging Mitral Technologies Where Are We Now? MICHAEL MACK, MD BAYLOR SCOTT & WHITE HEALTH DALLAS, TX

Transcatheter Mitral Innovations, Part II. Michael Mack, M.D. Baylor Scott & White Health

Transcatheter Mitral Valve for fmr: The Era of Too Many Options

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain

Transcatheter Mitral & Tricuspid Therapies. Bernard J. Zovighian Corporate Vice President

Next Generation Therapies: Aortic, Mitral and Beyond

Imaging to select patients for Transcatheter TV

Transcatheter Mitral Valve Interventions: Clinical Indications. Didier TCHETCHE, MD. Clinique Pasteur, Toulouse, France.

Mitral Valve Disease. James Hermiller, MD, FACC, FSCAI St Vincent Heart Center Indianapolis, IN

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine

Get Ready for Percutaneous Mitral Valve Approaches

TREATMENT OF SECONDARY MITRAL REGURGITATION VIA PERCUTANEOUS ANNULOPLASTY

The Edge-to-Edge Technique f For Barlow's Disease

Percutaneous Mitral Valve Repair

Transcatheter Mitral and Tricuspid Therapies

Routine MitraClip. Image Guidance Step by Step

Mitral Programme Update

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis

Update on Transcatheter Mitral Valve Repair and Replacment

SURGICAL AND TRANSCATHETER MITRAL VALVE REPLACEMENT VS. REPAIR: COMPETITION OR SYNERGY

Percutaneous Treatment of Mitral Insufficiency: Present and Future

Percutaneous Mitral Valve Intervention: QuantumCor Device

Posterior leaflet prolapse is the most common lesion seen

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Prognostic Impact of FMR

Sergio Berti Ospedale del Cuore Fondazione C.N.R. Reg Toscana Massa/Pisa

Atrioventricular valve repair: The limits of operability

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients?

Mitral and tricuspid regurgitation (TR) are

My Choice For Percutaneous Mitral Valve Replacement. Jose Luis Navia, MD.

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan

The HRT Mitral Bridge Technology for Functional MR

Percutaneous Valve Interventions. Percutaneous Valve Interventions

Percutaneous Mitral Valve Therapies

Cardioband: una chance per l insufficienza mitralica funzionale

Medical Technology. A Toolbox Will Be Needed to Treat Mitral Valve Disease: Repair and Replacement. Medical Technology. BMO Top 15 List Member

Edwards' solution for patients suffering from tricuspid valve disease

Sutureless Mitral and Tricuspid Clamp Valves

Surgical repair techniques for IMR: future percutaneous options?

Mitral regurgitation (MR) is present in 1.7% of the

Repair or Replacement

The Key Questions in Mitral Valve Interventions. Where Are We in 2018?

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Portico (St. Jude Medical Inc, St.

Percutaneous Tricuspid Valve Therapies: The Next Frontier? Is the Tricuspid Valve Relevant? Data and Guidelines for TV Interventions

Mitral valve (MV) regurgitation is common;

Transcatheter Mitral Valve Replacement. Lutter G, Lozonschi L

Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives. Bernard Iung Bichat Hospital, Paris

Coronary Sinus Annuloplasty for Mitral Regurgitation A look at several devices with the ability to reduce functional mitral regurgitation.

NeoChord Mitral Valve Repair. Department of Cardiac, Thoracic and Vascular Sciences University of Padua, Italy

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017

Prospects for the percutaneous repair of the mitral valve

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

Repair. Commercial Products Prior authorization is recommended for Commercial Products.

CLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ;

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

Durability of Mitral Valve Surgery: Repair, Replacement or simply a clip? Christoph Huber Chirurgie Cardio Vasculaire HUG

Truly Endoscopic Robotic mitral valve repair The new frontier

Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast ( )

Mitral Valve Disease, When to Intervene

Cite this article as:

MitraClip in the ICCU: Which Patient will Benefit?

Transcatheter Mitral Valve Repair

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

VALVULOPATIE: NUOVE SOLUZIONI.

Mitral valve treatment in advanced heart failure: Repair, Replacement, MitraClip. Nicola Buzzatti, MD San Raffaele Scientific Institute Milan, Italy

Conflict of Interests

Advancing Our Technology Leadership in Advanced Heart Failure. Investor and Analyst Conference Call and Webcast September 1, 2015

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Contemporary Management of Mitral Regurgitation Tailoring Treatment to The Patient Subset & Clinical Situation

Cardiology Research Newsletter

Surgery For Ebstein Anomaly

How to Perform a Valve Sparing Root Replacement Joseph S. Coselli, M.D.

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Who will Benefit from Percutaneous Management of Mitral Regurgitation? An Imaging Guide to Management

Ischemic Mitral Valve Disease: Repair, Replace or Ignore?

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique

Transcatheter Aortic Valve Replacement with Evolut-R

Percutaneous valve procedures: an update

Mitral Regurgitation Epidemiology and Classification

Surgical Repair of the Mitral Valve Presenter: Graham McCrystal Cardiothoracic Surgeon Christchurch Public Hospital

Percutaneous technologies to correct TR : Myth or Reality? Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

Percutaneous Mitral Valve Repair

Transcatheter mitral valve repair is considered investigational in all situations.

ready to repair product brochure PERFORMANCE INNOVATION DESIGN mitral solutions

Basic principles of Rheumatic mitral valve Repair

Direct Annuloplasty with QuantumCor: Device Evolution, Techniques and First-in-Man Results

REDUCING THE IMPACT OF SURGERY AND FACILITATING FASTER RECOVERY

Transcatheter Mitral Valve Replacement How Close Are We?

Transcription:

Percutaneous mitral annuloplasty Francesco Maisano MD, FESC San Raffaele Hospital Milano, Italy

Disclosure Consultant for Abbott, Medtronic, St Jude, Edwards, ValtechCardio Founder of 4Tech

Surgical techniques for MR Leaflet repair Annular remodeling

Annuloplasty Annuloplasty is routinely performed during MV repair to reduce and reshape the annulus Annuloplasty reduces stresses on the suture and on the valve structures and stabilizes annular diameter Lack of annuloplasty is associated to accelerated failure in the overall surgical population SI (kpa) - 647-520 - 394-267 - 140-134 + 113 + 240 + 367 + 493 + 620 + 747 +873 +100 0 Maisano F, et al Eur J Cardiothorac Surg. 1999;15:419-25 Gillinov et al J Thorac Cardiovasc Surg 1998;116:734-43

AV node Mitro aortic continuity Cx artery

CARILLON Mitral Contour System Advanced Delivery System 9F Curved Delivery Catheter Carillon XE2 Implant Handle Assembly 60, 70, 80 mm DA: 7-14 mm PA: 12-20 mm 7

TITAN Trial Baseline Characteristics Hoppe UC, Siminiak T, Haude M, et.al., European Heart J 2010:31;160-1. 8

TITAN Trial Major Adverse Event Rate Mortality Implanted: All Cause: 22% Cardiac: 11% Non-Implanted: All Cause: 24% Cardiac: 24% * Contrast-related acute renal failure in non-implanted patient. ** MAE s reviewed with DSMB; No relation to device identified Hoppe UC, Siminiak T, Haude M, et.al., European Heart J 2010:31;160-1. 9

TITAN Trial Reduction in Mitral Regurgitation Between groups comparison of paired absolute differences from baseline Hoppe UC, Siminiak T, Haude M, et.al., European Heart J 2010:31;160-1. 10

TITAN Trial Reverse Remodeling Between groups comparison of paired absolute differences from baseline Hoppe UC, Siminiak T, Haude M, et.al., European Heart J 2010:31;160-1. 11

Customized therapy Mitral disease is complex, lending itself to some customization Potential to use 1, 2 or 3 implants Customize the location of the implant to match the MR jet Customize the amount of plication to match the heart size, extent of MR 13 13

steerable guide catheter is brought to the mitral annulus 15 15

Drive a wire through the selected location on the annulus 17 17

Deliver pledget over the wire 19 19

Plicate and Lock 21 21

Atrium View Ventricle View Two Implants (~17mm Plication) 22 22

GDS Accucinch System Percutaneous Basal Ventriculoplasty 2

GSS Accucinch IMPLANT Surgically Placed GUIDE CATHETER Percutaneous GUIDE CATHETER + IMPLANT Percutaneous System Anchors Anchors Dr. J.G. Webb, St. Paul s Hospital, Vancouver Prof. J. Schofer, Medizinisches Versorgungszentrum, Hamburg

Subvalvar cinching

Valtech Cardioband Transcatheter mitral sutureless and adjustable posterior annuloplasty system Fully percutaneous direct annuloplasty the only approach with a proven surgical background

The transfemoral percutaneous Cardioband annuloplasty system Antigrade approach (transeptal) Annular fixation in supraannular position Annular dimensions are tuned using the adjustment tool

Cardioband delivery system Implant Transeptal Guide Catheter Implant Delivery System Anchor Drive Stand Cardioband Implant

Transseptal guide insertion

Therapy catheter insertion

First anchor implant Anchors are implanted individually by clockwise rotation of torquable catheter A clutch limiter prevents overrotation All anchors are repositionable and retrievable

AL to PM commissure

Contraction catheter insertion and automatic docking

Annular dimension adjustment by Cardioband contraction/relaxation Annular area change Transmitral gradient change

LA wall Circumflex artery Coronary sinus mitralign Fibrous annulus Posterior LV wall

Cardinal Ring Adjustment optimization of coaptation, in all cases * p=0.001 The Cardinal adjustable ring is implanted on the arrested heart, under direct vision, and adjusted onthe beating heart, under physiologic conditions Base line No adjustment Post adjustment Better coaptation and no residual MR = less recurrent surgery Cardinal multicenter EU trial

Pre-Clinical Experience Chronic Animals 10 Chronic Animals 90-day study Full Tissue Integration Acute Animals >90 acute animals

Transcatheter Heart Valve Repair 100% Solution When chord replacement is used in surgery 70% of mitral repairs can be done by Annuloplasty and Chords only* Percutaneous Annuloplasty Percutaneous Chordae Replacement Fully Percutaneous Mitral Repair *Seeburger et al. Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients; Eur J Cardiothorac Surg 2008;34:760-765

Percutaneous annuloplasty Annular dilatation and remodeling is an important feature contributing to MR Several percutaneous technologies are developing Expand indcations Improve early outcomes Improve durability Challenge surgical outcomes